{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:06:22Z","timestamp":1790082382338,"version":"4.0.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"DOI":"10.1007\/s11239-025-03174-3","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T14:42:50Z","timestamp":1756996970000},"page":"228-236","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of half-dose thrombolysis on hypoxemia duration in intermediate risk pulmonary embolism"],"prefix":"10.1007","volume":"59","author":[{"given":"Cyrus","family":"Moini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehran","family":"Monchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umamaheswari","family":"Ramamourthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romuald","family":"Awede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Cabot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kmar","family":"Hraiech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7111-4107","authenticated-orcid":false,"given":"S\u00e9bastien","family":"Jochmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"key":"3174_CR1","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","volume":"118","author":"AM Wendelboe","year":"2016","unstructured":"Wendelboe AM, Raskob GE (2016) Global burden of thrombosis: epidemiologic aspects. Circ Res 118:1340\u20131347. https:\/\/doi.org\/10.1161\/CIRCRESAHA.115.306841","journal-title":"Circ Res"},{"key":"3174_CR2","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1164\/rccm.200506-862OC","volume":"172","author":"D Aujesky","year":"2005","unstructured":"Aujesky D, Obrosky DS, Stone RA et al (2005) Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med 172:1041\u20131046. https:\/\/doi.org\/10.1164\/rccm.200506-862OC","journal-title":"Am J Respir Crit Care Med"},{"key":"3174_CR3","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1001\/archinternmed.2010.199","volume":"170","author":"D Jim\u00e9nez","year":"2010","unstructured":"Jim\u00e9nez D, Aujesky D, Moores L et al (2010) Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med 170:1383\u20131389. https:\/\/doi.org\/10.1001\/archinternmed.2010.199","journal-title":"Arch Intern Med"},{"key":"3174_CR4","doi-asserted-by":"publisher","first-page":"1901647","DOI":"10.1183\/13993003.01647-2019","volume":"54","author":"SV Konstantinides","year":"2019","unstructured":"Konstantinides SV, Meyer G, Becattini C et al (2019) 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS): the task force for the diagnosis and management of acute pulmonary embolism of the European society of cardiology (ESC). Eur Respir J 54:1901647. https:\/\/doi.org\/10.1183\/13993003.01647-2019","journal-title":"Eur Respir J"},{"key":"3174_CR5","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1161\/CIR.0b013e318214914f","volume":"123","author":"MR Jaff","year":"2011","unstructured":"Jaff MR, McMurtry MS, Archer SL et al (2011) Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. Circulation 123:1788\u20131830. https:\/\/doi.org\/10.1161\/CIR.0b013e318214914f","journal-title":"Circulation"},{"key":"3174_CR6","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.amjcard.2012.09.027","volume":"111","author":"M Sharifi","year":"2013","unstructured":"Sharifi M, Bay C, Skrocki L et al (2013) Moderate pulmonary embolism treated with thrombolysis (from the MOPETT Trial). Am J Cardiol 111:273\u2013277. https:\/\/doi.org\/10.1016\/j.amjcard.2012.09.027","journal-title":"Am J Cardiol"},{"key":"3174_CR7","doi-asserted-by":"publisher","first-page":"1701775","DOI":"10.1183\/13993003.01775-2017","volume":"51","author":"S Barco","year":"2018","unstructured":"Barco S, Vicaut E, Klok FA et al (2018) Improved identification of thrombolysis candidates amongst intermediate-risk pulmonary embolism patients: implications for future trials. Eur Respir J 51:1701775. https:\/\/doi.org\/10.1183\/13993003.01775-2017","journal-title":"Eur Respir J"},{"key":"3174_CR8","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"S Schulman","year":"2005","unstructured":"Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis (2005) Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients. J Thromb Haemost JTH 3:692\u2013694. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01204.x","journal-title":"J Thromb Haemost JTH"},{"key":"3174_CR9","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.accpm.2020.10.012","volume":"39","author":"E Toulouse","year":"2020","unstructured":"Toulouse E, Lafont B, Granier S et al (2020) French legal approach to patient consent in clinical research. Anaesth Crit Care Pain Med 39:883\u2013885. https:\/\/doi.org\/10.1016\/j.accpm.2020.10.012","journal-title":"Anaesth Crit Care Pain Med"},{"key":"3174_CR10","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.15537\/smj.2018.11.22717","volume":"39","author":"L-Y Zhang","year":"2018","unstructured":"Zhang L-Y, Gao B-A, Jin Z et al (2018) Clinical efficacy of low dose recombinant tissue-type plasminogen activator for the treatment of acute intermediate-risk pulmonary embolism. Saudi Med J 39:1090\u20131095. https:\/\/doi.org\/10.15537\/smj.2018.11.22717","journal-title":"Saudi Med J"},{"key":"3174_CR11","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1136\/jim-2021-001816","volume":"69","author":"ES Yilmaz","year":"2021","unstructured":"Yilmaz ES, Uzun O (2021) Low-dose thrombolysis for submassive pulmonary embolism. J Investig Med Off Publ Am Fed Clin Res 69:1439\u20131446. https:\/\/doi.org\/10.1136\/jim-2021-001816","journal-title":"J Investig Med Off Publ Am Fed Clin Res"},{"key":"3174_CR12","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1093\/eurheartj\/ehy873","volume":"40","author":"S Barco","year":"2019","unstructured":"Barco S, Mahmoudpour SH, Planquette B et al (2019) Prognostic value of right ventricular dysfunction or elevated cardiac biomarkers in patients with low-risk pulmonary embolism: a systematic review and meta-analysis. Eur Heart J 40:902\u2013910. https:\/\/doi.org\/10.1093\/eurheartj\/ehy873","journal-title":"Eur Heart J"},{"key":"3174_CR13","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1056\/NEJMoa021274","volume":"347","author":"S Konstantinides","year":"2002","unstructured":"Konstantinides S, Geibel A, Heusel G et al (2002) Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med 347:1143\u20131150. https:\/\/doi.org\/10.1056\/NEJMoa021274","journal-title":"N Engl J Med"},{"key":"3174_CR14","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1056\/NEJMoa1302097","volume":"370","author":"G Meyer","year":"2014","unstructured":"Meyer G, Vicaut E, Danays T et al (2014) Fibrinolysis for patients with intermediate-risk pulmonary embolism. N Engl J Med 370:1402\u20131411. https:\/\/doi.org\/10.1056\/NEJMoa1302097","journal-title":"N Engl J Med"},{"key":"3174_CR15","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1001\/jama.2014.5990","volume":"311","author":"S Chatterjee","year":"2014","unstructured":"Chatterjee S, Chakraborty A, Weinberg I et al (2014) Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. JAMA 311:2414\u20132421. https:\/\/doi.org\/10.1001\/jama.2014.5990","journal-title":"JAMA"},{"key":"3174_CR16","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1111\/jth.12608","volume":"12","author":"S Nakamura","year":"2014","unstructured":"Nakamura S, Takano H, Kubota Y et al (2014) Impact of the efficacy of thrombolytic therapy on the mortality of patients with acute submassive pulmonary embolism: a meta-analysis. J Thromb Haemost 12:1086\u20131095. https:\/\/doi.org\/10.1111\/jth.12608","journal-title":"J Thromb Haemost"},{"key":"3174_CR17","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.thromres.2013.12.026","volume":"133","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Zhai Z, Liang L et al (2014) Lower dosage of Recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: a systematic review and meta-analysis. Thromb Res 133:357\u2013363. https:\/\/doi.org\/10.1016\/j.thromres.2013.12.026","journal-title":"Thromb Res"},{"key":"3174_CR18","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1378\/chest.09-0765","volume":"137","author":"C Wang","year":"2010","unstructured":"Wang C, Zhai Z, Yang Y et al (2010) Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial. Chest 137:254\u2013262. https:\/\/doi.org\/10.1378\/chest.09-0765","journal-title":"Chest"},{"key":"3174_CR19","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/CCM.0000000000006162","volume":"52","author":"R Melamed","year":"2024","unstructured":"Melamed R, Tierney DM, Xia R et al (2024) Safety and efficacy of reduced-dose versus full-dose alteplase for acute pulmonary embolism: a multicenter observational comparative effectiveness study. Crit Care Med 52:729\u2013742. https:\/\/doi.org\/10.1097\/CCM.0000000000006162","journal-title":"Crit Care Med"},{"key":"3174_CR20","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1055\/a-1653-4699","volume":"122","author":"O Sanchez","year":"2022","unstructured":"Sanchez O, Charles-Nelson A, Ageno W et al (2022) Reduced-dose intravenous thrombolysis for acute intermediate-high-risk pulmonary embolism: rationale and design of the pulmonary embolism international thrombolysis (PEITHO)-3 trial. Thromb Haemost 122:857\u2013866. https:\/\/doi.org\/10.1055\/a-1653-4699","journal-title":"Thromb Haemost"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03174-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11239-025-03174-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-025-03174-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T13:41:51Z","timestamp":1770644511000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11239-025-03174-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["3174"],"URL":"https:\/\/doi.org\/10.1007\/s11239-025-03174-3","relation":{},"ISSN":["1573-742X"],"issn-type":[{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,4]]},"assertion":[{"value":"23 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments. In accordance with French and European laws (Loi Informatique et Libert\u00e9, General Data Protection Regulation), patients were informed of the purpose of the study and could refuse use of their personal data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Generative AI or AI-assisted technology has not been used at any step of this research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI in scientific writing"}}]}}